HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2007-1009v1 26/6/1414    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Google Scholar Articles by Shu, Q. Articles by Li, X.-N. PubMed PubMed Citation Articles by Shu, Q. Articles by Li, X.-N.

CANCER STEM CELLS

Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133⁺ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma

^aLaboratory of Molecular Neuro-Oncology,
^bTexas Children's Cancer Center,
^cDepartment of Pathology and
^dNeurosurgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA
^eDepartment of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Key Words. Medulloblastoma • Glioma • Orthotopic xenograft model • Cancer stem cell

Correspondence: Xiao-Nan Li, M.D., Ph.D., Laboratory of Molecular Neuro-Oncology, Texas Children's Cancer Center, Texas Children's Hospital, 6621 Fannin St, MC 3-3320, Houston, Texas 77030, USA. Telephone: 832-824-4580; Fax: 832-825-4038; e-mail: xiaonan{at}bcm.tmc.edu

Received November 29, 2007; accepted for publication March 24, 2008.
First published online in STEM CELLS EXPRESS   April 10, 2008.

Recent identification of cancer stem cells in medulloblastoma (MB) and high-grade glioma has stimulated an urgent need for animal models that will not only replicate the biology of these tumors, but also preserve their cancer stem cell pool. We hypothesize that direct injection of fresh surgical specimen of MB and high-grade glioma tissues into anatomically equivalent locations in immune-deficient mouse brains will facilitate the formation of clinically accurate xenograft tumors by allowing brain tumor stem cells, together with their non-stem tumor and stromal cells, to grow in a microenvironment that is the closest to human brains. Eight of the 14 MBs (57.1%) and two of the three high-grade gliomas (66.7%) in this study developed transplantable (up to 12 passages) xenografts in mouse cerebellum and cerebrum, respectively. These xenografts are patient specific, replicating the histopathologic, immunophenotypic, invasive/metastatic, and major genetic (analyzed with 10K single nucleotide polymorphism array) abnormalities of the original tumors. The xenograft tumor cells have also been successfully cryopreserved for long-term preservation of tumorigenicity, ensuring a sustained supply of the animal models. More importantly, the CD133⁺ tumor cells, ranging from 0.2%–10.4%, were preserved in all the xenograft models following repeated orthotopic subtransplantations in vivo. The isolated CD133⁺ tumor cells formed neurospheres and displayed multi-lineage differentiation capabilities in vitro. In summary, our study demonstrates that direct orthotopic transplantation of fresh primary tumor cells is a powerful approach in developing novel clinical relevant animal models that can reliably preserve CD133⁺ tumor cell pools even during serial in vivo subtransplantations.

Disclosure of potential conflicts of interest is found at the end of this article.